{
 "PrintNo":"A663","Version":"B","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2020-12-30T11:15:39.962658Z","Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-05-19","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-06","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"},
  {"Text":"AMEND (T) AND RECOMMIT TO HEALTH","Date":"2022-05-06","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 663A","Date":"2022-05-06","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"AMEND AND RECOMMIT TO HEALTH","Date":"2022-05-19","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"PRINT NUMBER 663B","Date":"2022-05-19","Chamber":"ASSEMBLY","Version":"B"}
 ],
 "Sponsors":[
  {"ID":1139,"Name":"Daniel Rosenthal","Short":"ROSENTHAL D"},{"ID":621,"Name":"Sandy Galef","Short":"GALEF"},
  {"ID":1250,"Name":"John Salka","Short":"SALKA"},{"ID":1128,"Name":"Inez E. Dickens","Short":"DICKENS"},
  {"ID":500,"Name":"William Colton","Short":"COLTON"},{"ID":1116,"Name":"Jaime R. Williams","Short":"WILLIAMS"},
  {"ID":906,"Name":"Rebecca Seawright","Short":"SEAWRIGHT"},{"ID":457,"Name":"Vivian Cook","Short":"COOK"},
  {"ID":522,"Name":"Daniel O'Donnell","Short":"O'DONNELL"},{"ID":907,"Name":"Jo Anne Simon","Short":"SIMON"},
  {"ID":622,"Name":"Thomas Abinanti","Short":"ABINANTI"},{"ID":1259,"Name":"Jonathan Jacobson","Short":"JACOBSON"},
  {"ID":1241,"Name":"Judy Griffin","Short":"GRIFFIN"}
 ],
 "Title":"Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs",
 "Summary":"Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.",
 "LawSection":"Insurance Law","LawCode":"Add ยง111-a, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to requiring certain manufacturers of prescription drugs to notify the superintendant of any proposed increase of the wholesale acquisition cost of such prescription drugs",
 "SameAsPrintNo":"S7499-2021","PreviousVersions":["A8253-2019"]
}